Meanwhile, the Pause algorithm reduced LINQ II false pause alerts by 97.4% and preserved 100% of true pause alerts. The AccuRhythm algorithms will be released later this year for use by all ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

There were 13 adverse events related to the intervention in 59 people, three of them related to the Reveal LINQ ICM system ..

NIM® systems monitor EMG activity from multiple mucles. If there is a change in nerve function, the NIM system may provide audible and visual warnings to help reduce the risk of nerve damage.

The Simulus ® Adjustable Annuloplasty Ring and Band are fully flexible and enable finite adjustments. Based on preference and patient need, surgeons can choose between the Simulus Adjustable ...

Hexagon Health and its founder Dr. Shirin Towfigh diled a lawsuit in Delaware today against Medtronic (MDT), alleging Medtronic infringed three of Hexagon’s patents related to hernia mesh treatment ...

Abbott will make a continuous glucose-monitoring device for diabetic patients that will work with Medtronic’s automated ...

The Affera system, with its globular Sphere-9 catheter, was acquired by Medtronic in August 2022 through its $925 million purchase of the device’s eponymous developer. Not long thereafter ...

Medtronic has announced US Food and Drug Administration (FDA) approval to conduct an early feasibility study using the Affera Mapping and Ablation System for sustained VT, a serious heart condition.

RBC Capital raised the firm’s price target on Medtronic to $98 from $92 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q3 results. The firm’s ...

Need a new idea to keep kids entertained? Try stargazing. Free learning activities and videos about the solar system Free learning activities and videos about the solar system Free learning ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...